EDITAS MEDICINE, INC. (EDIT) Operating cash flow 2016–2025
EDITAS MEDICINE, INC. (EDIT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$165.2MFY2025 · since FY2016: -$50.2M → -$165.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$165.2M | +21.4% |
| FY2024 | -$210.3M | -59.1% |
| FY2023 | -$132.2M | +25.5% |
| FY2022 | -$177.3M | -8.3% |
| FY2021 | -$163.8M | +8.9% |
| FY2020 | -$179.8M | -342.2% |
| FY2019 | -$40.7M | +11.0% |
| FY2018 | -$45.7M | -385.4% |
| FY2017 | -$9.4M | +81.3% |
| FY2016 | -$50.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More EDIT financial trends
EDIT RevenueEDIT Net incomeEDIT Net marginEDIT Gross profitEDIT Gross marginEDIT Operating incomeEDIT Operating marginEDIT Free cash flowEDIT Capital expendituresEDIT Return on equityEDIT Stock buybacksEDIT Dividends paidEDIT Total assetsEDIT Total liabilitiesEDIT Shareholders’ equityEDIT overview →